News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Stanley Ozogbo: It was an enriching experience presenting a poster at the ASCO24 conference
Photo take from Stanley Ozogbo/X
Jun 7, 2024, 00:02

Stanley Ozogbo: It was an enriching experience presenting a poster at the ASCO24 conference

Stanley Ozogbo, Resident Physician at Mercy Health, shared on X:

“It was an enriching experience presenting a poster at the ASCO24 conference.

Our research highlighted the declining trend of palliative care utilization among patients with prostate cancer. It demonstrated the increasing racial disparities in with blacks being at a disadvantage.”

Stanley Ozogbo

Source: Stanley Ozogbo/X

ASCO24 cancer OncoDaily Oncology Stanley Ozogbo
Special Coverage
Blog
Jun 2, 2025, 06:54
Sarah Cannon Research Institute - Skip Burris was Honored with Endowed ASCO-Conquer Cancer Award in His Name
Insight
Jun 2, 2025, 06:41
Martin Zapata Laguado: New players in the management of mRCC patients
Insight
Jun 2, 2025, 06:19
Martin Zapata Laguado: KN564 maintain benefit on OS in ccRCC
Science
Jun 2, 2025, 06:09
Gerard Mawhinney: 14-year review of the Oxford Spinal Sarcoma Service on primary spinal tumour care
Blog
Jun 2, 2025, 05:45
ABC Global Alliance President, Fatima Cardoso, received the prestigious 2025 Yvonne Award for Lifetime Achievement in Oncology
Oncolibrary
Jun 2, 2025, 05:43
ctDNA Analysis in the Phase 3 NIAGARA Trial: Perioperative Durvalumab with Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
Science
Jun 2, 2025, 05:32
ALNEO Phase II Trial Highlights Promising Role of Perioperative Alectinib in Stage III Resectable ALK-Positive NSCLC
Science
Jun 2, 2025, 05:14
SAVANNAH Trial Highlights Synergistic Effect of Savolitinib and Osimertinib in EGFR-Mutant NSCLC with MET-Mediated Resistance
Science
Jun 2, 2025, 04:58
NATALEE Trial Subgroup Analysis Confirms Ribociclib Benefit Across Age and Menopausal Status in High-Risk HR+/HER2− Early Breast Cancer
Science
Jun 2, 2025, 04:38
T-DXd Demonstrates Promising Activity in Desmoplastic Small Round Cell Tumor (DSRCT)
Oncolibrary
Jun 2, 2025, 04:26
TROPION-Lung02: First-Line Dato-DXd Plus Pembrolizumab With or Without Platinum Chemotherapy Delivers Promising Results in Advanced Non-Small Cell Lung Cancer
Science
Jun 2, 2025, 04:17
NeoSTAR Trial Updates Reports Promising Early Results of Sacituzumab Govitecan Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer